DAVID CORRY to Anti-Bacterial Agents
This is a "connection" page, showing publications DAVID CORRY has written about Anti-Bacterial Agents.
Connection Strength
0.105
-
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nat Microbiol. 2026 Apr; 11(4):1100-1112.
Score: 0.105